HTA170 Including Decision-Analytic Benefit-Harm Evaluation in HTA - Different Age Ranges and Screening Intervals in Breast Cancer Screening in Germany
Abstract
Authors
G Sroczynski LR Hallsson N Mühlberger F Kuehne B Jahn H Kölsch S Sauerland K Angelescu U Siebert